oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Trends in overall survival in Swedish patients withprimary metastatic breast cancer – 1994 to 2014
Örebro University, School of Medical Sciences.
2018 (English)Independent thesis Advanced level (degree of Master (Two Years)), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

Introduction Each year approximately 7600 individuals are diagnosed with breast cancer in Sweden, someof which with primary metastatic breast cancer (PMBC). Several new drugs for treatingmetastatic breast cancer have been introduced during the last three decades, many of whichclaims to prolong survival.

Aim The aim of this study was to determine if the median overall survival (OS) had improved from1994 to 2014 in patients with PMBC in the healthcare region of Uppsala/Örebro.

Material and methods Between 1994 and 2014, 871 patients were diagnosed with PMBC in the healthcare region ofUppsala/Örebro, 168 in 1994-1999, 362 in 2000-2006 and 341 in 2007-2014. The patientcharacteristics were compared with Chi2 test and the Kaplan-Meier method was used tocalculate the median survival for each group. Univariate and multivariate analyses were usedto calculate factors affecting survival.

Results The estimated median OS was 12.1 months in 1994-1999, 22.0 months in 2000-2006 and 19.7months in 2007-2014. There was a statistically significant difference in median OS between1994-1999 and 2000-2006, and between 1994-1999 and 2007-2014, but no significantdifference was seen between 2000-2006 and 2007-2014. Increasing age had a negative impacton survival, whereas estrogen receptor-positivity and Grade I-II correlated with prolongedsurvival. Women who had undergone surgery of the breast tumor had longer survival thanthose who had not had surgery.

Conclusion The median OS in patients with PMBC have improved from 1994-1999 to 2000-2014. Nodifference was seen between 2000-2006 and 2007-2014.

Place, publisher, year, edition, pages
2018.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:oru:diva-68117OAI: oai:DiVA.org:oru-68117DiVA, id: diva2:1234440
Subject / course
Medicine
Supervisors
Examiners
Available from: 2018-07-25 Created: 2018-07-24 Last updated: 2018-07-25Bibliographically approved

Open Access in DiVA

fulltext(674 kB)2 downloads
File information
File name FULLTEXT01.pdfFile size 674 kBChecksum SHA-512
ebf35b1a197b6a89e62bed3336c24e85d11989f9a2a4e67169883d16f2b325241092291204e548a0bfdf1ef4044a13c95ddb462c5d932d35474d36ab4bfecb15
Type fulltextMimetype application/pdf

By organisation
School of Medical Sciences
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 2 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf